Zydus Wellness share price

Balanced risk
  • 28%Low risk
  • 28%Moderate risk
  • 28%Balanced risk
  • 28%High risk
  • 28%Extreme risk
  • 2,001.75(-3.16%)
    June 20, 2025 15:49:31 PM IST
    • NSE
    • BSE
  • Vol : 303.02K (NSE + BSE)
    Last 20 day avg : 138.05 K

Zydus Wellness is trading -3.16% lower at Rs 2,001.75 as compared to its last closing price. Zydus Wellness has been trading in the price range of 2,105.40 & 1,988.40. Zydus Wellness has given 4.79% in this year & 6.62% in the last 5 days. Zydus Wellness has TTM P/E ratio 30.83 as compared to the sector P/E of 19.22.There are 5 analysts who have initiated coverage on Zydus Wellness. There are 4 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 171.90 Crores in its last quarter.Listed peers of Zydus Wellness include Lt Foods (1.49%), Godrej Agrovet (1.99%), Zydus Wellness (-3.16%).The Mutual Fund holding in Zydus Wellness was at 11.61% in 31 Mar 2025. The MF holding has decreased from the last quarter. The FII holding in Zydus Wellness was at 3.29% in 31 Mar 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Key Metrics

Updated on Jun 20, 2025, 02:22 PM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.29
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    2.32
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    37.90
    Higher than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.60
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.03
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
1,988.40
Highest
2,105.40
52 week range
Lowest
1,493.00
Highest
2,484.00
Zydus Wellness Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsThe company's revenue grew in March quarter by 16.68% from Rs 913.10 crore to Rs 782.60 crore, year-on-year
    • financial-insightsThe company has grown its March quarter profit by 14.37% from Rs 150.30 crore to Rs 171.90 crore, year-on-year
    • financial-insightsThe debt to equity of the company is lower than the industry median
    • financial-insightsCompany can comfortably pay off its interest obligations with its earnings
Zydus Wellness Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 2,108.25
  • R2
  • 2,268.80
  • R3
  • 2,381.30
Pivot1,995.75
  • S1
  • 1,835.20
  • S2
  • 1,722.70
  • S3
  • 1,562.15
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Zydus Wellness Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Lt Foods
Neutral
431.501.4915,059.6325.133.950.4611.55
Godrej Agrovet
Neutral
760.001.9914,652.5034.206.171.4422.75
Zydus Wellness
Bullish
2,001.75-3.1612,817.0938.312.30.290.02
Balrampur Chini Mills
Bullish
596.001.1512,033.3827.333.140.5112.91
Ccl Products India
Neutral
787.95-1.0810,469.4334.305.40.5628.36
Zydus Wellness Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Zydus Wellness is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) holds a high stake in the company at 69.63%
    • InsightsPromoter(s) have increased the stake in the company in last 12 months
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has decreased by 0.08 percentage points from previous quarter
    • InsightsMutual Funds holding has decreased by 0.26 percentage points from previous quarter
    Mutual Fund Ownership
    View all
    Quant Consumption Fund Regular Growth
    NA
    • Amount Invested (Cr.) 22.18
    • % of AUM 8.09
    Quant ESG Equity Fund Regular Growth
    4/5
    • Amount Invested (Cr.) 22.62
    • % of AUM 7.57
    Quant Healthcare Fund Regular Growth
    NA
    • Amount Invested (Cr.) 25.02
    • % of AUM 6.00
    Quant Manufacturing Fund Regular Growth
    NA
    • Amount Invested (Cr.) 48.74
    • % of AUM 5.61
    Bajaj Finserv Consumption Fund Regular Growth
    NA
    • Amount Invested (Cr.) 13.60
    • % of AUM 2.38
    Zydus Wellness Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-05-19Audited Results, Dividend & Stock Split
    2025-02-04Quarterly Results
    2024-11-11Quarterly Results
    2024-08-02Quarterly Results
    2024-05-14Audited Results & Final Dividend
    About the company Zydus Wellness
    • IndustryFood Processing
    • ISININE768C01010
    • BSE Code531335
    • NSE CodeZYDUSWELL
    Zydus Wellness Limited is an India-based consumer company. The Company is focused on providing health and wellness-oriented products across two primary segments: Food & Nutrition and Personal Care. The Food & Nutrition segment includes Sweeteners, Complan, Glucon-D, and Nutralite. The Personal Care segment includes Nycil and Everyuth. Its brands also include I'm lite, and SugarFree D’lite. Everyuth brand is a pioneer in facial skin cleansing, utilize natural ingredients for effective skincare. The Nycil brand is an anti-bacterial formula that absorbs sweat, fights body odour, soothes itching, calms rashes, and prevents prickly heat. Complan is a Nutrition drink rich in protein. Its Sugar Free is a prominent brand with various sugar substitutes for consumers. Nutralite is a cholesterol-free spread, including mayonnaise and chocolate spreads, converging its dairy portfolio featuring DoodhShakti ghee and butter under the brand Nutralite.
    • Management Info
    • Tarun AroraChief Executive Officer, Whole Time Director
    • Umesh ParikhChief Financial Officer
    • Nandish JoshiCompany Secretary, Compliance Officer
    Zydus Wellness Share Price FAQs

    Zydus Wellness is trading at 2001.75 as on Fri Jun 20 2025 10:19:31. This is -3.16% lower as compared to its previous closing price of 2067.15.

    The market capitalization of Zydus Wellness is 12817.09 Cr as on Fri Jun 20 2025 10:19:31.

    The average broker rating on Zydus Wellness is Strong Buy. The breakup of analyst rating is given below -

    • 4 analysts have given a strong buy rating
    • 0.00 analysts have given a buy rating
    • 1 analysts have given a hold rating
    • 0.00 analysts have given a sell rating
    • 0.00 analysts have given a strong sell rating

    The 52 wk high for Zydus Wellness is 2484.00 whereas the 52 wk low is 1493.00

    Zydus Wellness can be analyzed on the following key metrics -

    • TTM P/E: 30.83
    • Sector P/E: 19.22
    • Dividend Yield: 0.29%
    • D/E ratio: 0.03

    Zydus Wellness reported a net profit of 346.90 Cr in 2025.

    The Mutual Fund Shareholding was 11.61% at the end of 31 Mar 2025.